Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy

Triple-negative breast cancers (TNBCs) are the most aggressive and hard-to-treat breast tumors with poor prognosis, and exploration for novel therapeutic drugs is impending. Arctigenin (Atn), a bioactive lignan isolated from seeds of Arctium lappa L, has been reported to inhibit many cancer types; h...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Tingting, Cao, Wei, Shen, Wanxiang, Zhang, Liang, Gu, Xinsheng, Guo, Yang, Tsai, Hsiang-i, Liu, Xuewen, Li, Jian, Zhang, Jingxuan, Li, Shan, Wu, Fuyun, Liu, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352123/
https://www.ncbi.nlm.nih.gov/pubmed/27861147
http://dx.doi.org/10.18632/oncotarget.13393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352123/
https://www.ncbi.nlm.nih.gov/pubmed/27861147
http://dx.doi.org/10.18632/oncotarget.13393

Ejemplares similares